Mergers & Acquisitions - Bayer

Filter

Current filters:

Bayer

Popular Filters

Bayer to buy Chinese OTC/TCM drugmaker Dihon Pharma

27-02-2014

Germany’s leading pharma firm Bayer says it plans to acquire 100% of Dihon Pharmaceutical, a privately…

BayerDihon PharmaceuticalMergers & AcquisitionsPharmaceutical

Way clear for Bayer to complete Algeta acquisition

26-02-2014

The way is now clear for Germany’s Bayer to acquire Norwegian pharmaceutical company Algeta, under…

AlgetaBayerMergers & AcquisitionsOncologyPharmaceuticalXofigo

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

Bayer takes advantage of low interest rates, issuing 2 billion euros of bonds

22-01-2014

German pharma and life sciences group Bayer says it is taking advantage of currently low interest rates…

AlgetaBayerFinancialMergers & AcquisitionsPharmaceutical

Bayer confirms plans to acquire Norway’s Algeta

Bayer confirms plans to acquire Norway’s Algeta

19-12-2013

German drugs and chemicals major Bayer has officially announced its intention to acquire Norwegian pharmaceutical…

AlgetaBayerGermanyMergers & AcquisitionsNorwayOncologyPharmaceuticalXofigo

Norway’s Algeta confirms takeover bid approach from Bayer

Norway’s Algeta confirms takeover bid approach from Bayer

26-11-2013

In response to recent media commentary, the board of directors of Norway’s Algeta this morning confirmed…

AlgetaBayerMergers & AcquisitionsNorwayOncologyPharmaceuticalXofigo

Onyx Pharma accepts increased bid from Amgen

27-08-2013

Amgen (Nasdaq: AMGN), the world largest independent biotech group, said on Sunday (August 25) that the…

AmgenBayerBiotechnologyKyprolisMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizer

Onyx Pharma rejects Amgen's unsolicited $120 per share takeover offer

01-07-2013

Following a day of speculation and rumor on Friday, US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX)…

AmgenBayerBiotechnologyCelgeneMergers & AcquisitionsOncologyOnyx PharmaceuticalsPfizerRoche

Bayer to strengthen consumer business with Steigerwald acquisition

17-05-2013

Germany's Bayer (BAYN: DE) has signed an agreement to acquire 100% of the shares of Steigerwald Arzneimittelwerk…

BayerMergers & AcquisitionsPharmaceuticalSteigerwald

Bayer to acquire Conceptus for about $1.1 billion

29-04-2013

German drugs and chemical major Bayer (BAYN: DE) has signed an agreement to acquire Conceptus (Nasdaq:…

BayerConceptusEssureMergers & AcquisitionsPharmaceuticalReproductiveWomen's Health

Reckitt Benckiser trumps Bayer's bid for control of Schiff Nutritional

16-11-2012

In a move that looks set to thwart Germany-based Bayer's (BAYN: DE) plans to acquire the US nutritional…

BayerMergers & AcquisitionsPharmaceuticalReckitt BenckiserSchiff Nutrition International

News briefs: GlaxoSmithKline and Bayer

24-05-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has said it would not proceed with its $2.59 billion hostile…

Antibiotics and Infectious diseasesBayerGlaxoSmithKlineMergers & AcquisitionsOncologyPharmaceuticalregorafenibRegulationResearch

Piramal buys molecular imaging portfolio from Bayer

16-04-2012

Indian drugmaker Piramal Healthcare (BSE: 500302) says it has signed an agreement to acquire worldwide…

BayerflorbetabenMergers & AcquisitionsPharmaceuticalPiramal Healthcare

Spectrum Pharma to acquire non-US rights to market Zevalin

26-01-2012

USA-based Spectrum Pharmaceuticals (NasdaqGS: SPPI) says it has entered into an agreement to acquire…

BayerMergers & AcquisitionsOncologyPharmaceuticalSpectrum PharmaceuticalsZevalin

Back to top